您当前的位置：
首页 >
文章列表页 >
Corrigendum to “A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance” [Genes Dis 694 (2019) 419–430]
更新时间：2022-06-24

    • Corrigendum to “A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance” [Genes Dis 694 (2019) 419–430]

    • Genes & Diseases   Vol. 7, Issue 1, (2020)
    • 作者机构：

      1. Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston,TX,Houston,USA,77204

      2. Drug Discovery Institute, University of Houston,TX,Houston,USA,77204

      3. Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University,Shanghai,China,200032

      4. Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University,Shanghai,China,200032

    • DOI：10.1016/j.gendis.2019.12.006    

      CLC：

    • Published：2020，

      Published Online：1 March 2020，

    扫 描 看 全 文

  • Wei Wang, Bo Hu, Jiang-Jiang Qin, et al. Corrigendum to “A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance” [Genes Dis 694 (2019) 419–430]. [J]. Genes & Diseases 7(1).(2020) DOI： 10.1016/j.gendis.2019.12.006.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0